NSE India 1840 (-1.6%)Tata Capital 975 (-7.1%)SBI Mutual Fund 2625 (-1.9%)Essar Oil 850 (-32%)Swiggy IPO 435 (0%)Swiggy CCPS 574410 (0%)HDB Financial 1075 (0%)Capgemini Technology 14000 (0%)OYO 54 (0%)AB Inbev Sabmiller 350 (0%)CIAL 452 (-1.7%)NSDL 990 (0%)Hero Fincorp 1425 (-23%)Care Health Insurance 186 (0%)BOAT 1675 (0%)HDFC Securities 9900 (-5.7%)Hinduja Leyland Finance 245 (0%)VIkram Solar Ltd 425 (-3.4%)Motilal Oswal 16 (-5.9%)Indian Potash 3175 (0%)Manjushree Technopack 950 (0%)Electrosteel Steel Ltd 46 (0%)Signify Innovations 1425 (0%)CSK 189 (-1.6%)Shriram Life Insurance 400 (0%)Elcid Investments 350000 (0%)Sterlite Power 565 (-5%)Carrier Airconditioning 545 (-5.2%)Pharmeasy 9 (0%)Fincare Small Finance Bank 260 (0%)Philips India 945 (0%)Orbis Financial 425 (-6.6%)MSEI 8.5 (6.3%)Otis Elevator 4250 (0%)Onix Renewable 18800 (-17.5%)Bharat Bank 16200 (-3.6%)Apollo Green Energy 255 (-19%)ESDS Software 425 (-2.3%)Merino Industries 3350 (0%)Pace Digitek 235 (0%)Veeda Clinical Research Limited 535 (0%)Philips Domestic Appliances 585 (0%)Indofil Industries 1295 (0%)Studds 685 (0%)Polymatech Electronics Pvt Ltd 64 (1.6%)Lava 46 (0%)Kurlon Ent 550 (0%)Mohan Meakin 2275 (-1.1%)Kannur International Airport 138 (0%)GKN Driveline 1425 (0%)Kurlon Ltd 1250 (0%)Matrix Gas and Renewables 525 (-29.5%)Lakeshore Hospital 135 (0%)Fino Paytech Limited 128 (-5.2%)Spray Engineering Devices 485 (-2.6%)Goodluck Defence 235 (-12.3%)NCDEX 220 (-2.2%)AV Thomas 22000 (0%)C2C Advanced systems 595 (0%)Bira 445 (-10.6%)Greenzo Energy Pvt Ltd 675 (-2.9%)Ring Plus 675 (0%)Honeywell Electrical Devices and Systems 5000 (0%)Urban Tots 78 (-7.1%)Schneider Electric 675 (0%)Inkel Ltd 22 (0%)HCIN Network 285 (0%)Maharashtra Knowledge Corporation MKCL 450 (0%)Martin and Harris Lab 850 (0%)NCL Buildtek 265 (-7%)PolicyX 67 (0%)Empire Spices and Foods ltd 585 (0%)AVPL 58 (0%)ACS Technologies 46 (0%)Resins and Plastic 650 (0%)ICEX 5 (0%)India Carbon ltd 975 (0%)Maxvalue Credits And Investments 7 (0%)RRP S4E Innovation 285 (0%)Ecosure Pulpmolding 56 (0%)Ramaraju Surgical Cotton 305 (0%)Quality Enviro 1350 (0%)ICL Fincorp 26 (0%)Assam Carbon Products 440 (0%)Amol Minechem Ltd 995 (-9.5%)Bazar India 26 (4%)Market Simplified 36 (0%)Silverline Technologies Ltd 12 (0%)Madbow 35 (0%)

15 Days Price Change

PharmEasy Unlisted Shares

  • PharmEasy
  • 414719

PharmEasy Unlisted Shares

  • 5Y
  • 3Y
  • 1Y
  • 6M
  • 1M

5 Year

3 Year

1 Year

6 Month

1 Month

About PharmEasy Unlisted Shares

Pharmeasy Share Price Full Details About the Company

PharmEasy is India's leading digital healthcare platform. It provides information, consultations, diagnostics tests, medicines, healthcare products, and services from registered and trusted pharmacies, leading diagnostic laboratories, and trusted doctors across India, serving every habitable zip code of the country. The journey of PharmEasy was started in 2015, when founders Dharmil Sheth, an MBA from IMT Ghaziabad and Dr. Dhaval Shah, MBBS from Rajiv Gandhi Medical College and MBA from XLRI Jamshedpur, came up with the idea of an online pharmacy to make healthcare affordable and accessible to one and all.

Overview of PharmEasy

They are India’s largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report. They operate an integrated, end-to-end business that aims to provide solutions for the healthcare needs of consumers across the following critical stages A. providing digital tools and information on illness and wellness.

B. Offering Teleconsultation.

C. Offering diagnostics and Radiology tests.

D. delivering treatment protocols including products and devices. PharmEasy custom-built proprietary technology, unified data platforms, supply chain capabilities, and a deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market are the capabilities that differentiate us.

These capabilities enable PharmEasy to provide each stakeholder in the healthcare value-chain, viz.: (a) channel (wholesalers, retailers, and chemists/institutions). (b) consultants (and hospitals), diagnostic and radiology labs. (c) consumers (d) companies (pharmaceutical, nutraceutical,medical devices.

The businesses have a presence across the country, with last-mile 163 capabilities to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing the ability to provide access in an affordable manner to the common man. The platforms have scaled across urban, semi-urban, and rural India, with an ability to serve people across income groups and geographies.

Journey of PharmEasy 

2015 - Started the journey in Mumbai and received angel funding.

2016 - Received Series-A funding and expanded into 5 cities. The same year they have started a home-diagnostics service.

2017 - Received Series-B funding and expanded into 700 cities. Launched online delivery of health care products.

2018 - Received Series-C funding and expanded PAN India presence.

2019 - Received Series-D funding and expanded more than 22000+ PIN codes.

2020- It has got merged with Ascent Health and 5 other companies to form API Holdings, to form India’s biggest online healthcare company.

2021 - It has purchased 66% stakes in Thyrocare and this is the first listed company to be acquired by any Unicorn in India. Currently, there is a team of 4000+ dedicated employees and have more than 10000+ retail stores working 24*7 to ensure medicines are delivered on time and at the best possible prices.

Funding History

March 2016 ~34 Crores
March 2017 ~104 Crores
April 2017 ~13 Crores
February 2018 ~13 Crores
September 2018 ~350 Crores
September 2018 ~2800 Crores
November 2019 ~1650 Crores
April 2021 ~2400 Crores
June 2021 ~150 Crores

Product and Services

If you check the website of PharmaEasy, you will find the following services;

(i) Order Online Medicine

How does it work?

Step-1: The buyer needs to upload the prescription. Once PharmEasy receives it, they verify and send the same to the Medical stores near the pin code.

Step-2: PhameEasy delivery agent then collects medicine from Pharmacy and delivers it to the user.

(ii) Healthcare Products Similar to buying the medicine you can buy various healthcare products such as Nutritions, Personal care, Skin Care, Ayurvedic Products, Life-Style Ailments Products.

(iii) Diagnostics Tests Under this service, you can book diagnostics tests under PharmEasy labs. PharmEasy labs is a diagnostic service offered by its partner lab Medlife Labs directly. Medlife is now being acquired by PharmEasy. As they have recently acquired Thyrocare, they are giving the option to book tests for these labs as well.

PharmEasy Business Model

The business model is very simple and straightforward. It connects buyers, suppliers, and distributors. Buyer has the option to choose services such as Medicine, Health-Care Products, book diagnostic tests, etc from the application and website. They get 1-2% commission on selling medicines, they get advertisement money for displaying products of various pharmaceuticals, Nutraceuticals, companies, etc., and also get income from diagnostics tests.



Fundamentals

PharmEasy Unlisted Shares Price
₹ 9
Per Equity Share
Lot Size
2500 Shares
52 Week High
₹ 13
52 Week Low
₹ 9
Depository
NSDL & CDSL
PAN Number
AASCA1201E
ISIN Number
INE0DJ201029
CIN
U60100MH2019PLC323444
RTA
Link Intime
Market Cap (in cr.)
₹ 5784
P/E Ratio
N/A
P/B Ratio
2.23
Debt to Equity
1.58
ROE (%)
-97.89
Book Value
4.03
Face Value
1
Total Shares
6426735432


Financials (Figures in Cr.)

  • Income Statement
  • Balance Sheet
  • Cash Flow
P&L Statement
P&L Statement 2021 2022 2023 2024
Revenue 2335 5729 6644 5664
Cost of Material Consumed 2267 5342 5669 4737
Gross Margins 2.91 6.76 14.67 16.37
Change in Inventory -114 -229 62 143
Employee Benefit Expenses 270 1459 1283 699
Other Expenses 482 1502 1051 731
EBITDA -570 -2345 -1421 -646
OPM -24.41 -40.93 -21.39 -11.41
Other Income 25 -1185 -2866 931
Finance Cost 43 258 666 728
D&A 33 159 243 216
EBIT -603 -2504 -1664 -862
EBIT Margins -25.82 -43.71 -25.05 -15.22
PBT -621 -3977 -5196 -2522
PBT Margins -26.6 -69.42 -78.21 -44.53
Tax 21 22 15 11
PAT -642 -3999 -5211 -2533
NPM -27.49 -69.8 -78.43 -44.72
EPS -25.08 -6.51 -8.48 -3.9
Financial Ratios
2021 2022 2023 2024
Operating Profit Margin -24.41 -40.93 -21.39 -11.41
Net Profit Margin -27.49 -69.8 -78.43 -44.72
Earning Per Share (Diluted) -25.08 -6.51 -8.48 -3.9
Balance Sheet
Assets 2021 2022 2023 2024
Fixed Assets 128 1025 912 734
CWIP 0.2 7.8 4 3.6
Investments 1 438 342 329
Trade Receivables 358 861 905 706
Inventory 406 761 688 556
Other Assets 4011.8 8305.2 5405 6061.4
Total Assets 4905 11398 8256 8390
Liabilities 2021 2022 2023 2024
Share Capital 25.6 614.2 614.2 649.6
FV 1 1 1 1
Reserves 3555.4 6408.3 1823 1938
Borrowings 585 2585 4120 4098
Trade Payables 365 459 413 413
Other Liabilities 374 1331.5 1285.8 1291.4
Total Liabilities 4905 11398 8256 8390
Cash-Flow Statement
Cash-Flow Statement 2021 2022 2023 2024
PBT -620 -3971 -5196 -2522
OPBWC -427 -1474 -637 -214
Change in Receivables -99 -226 -112 30
Change in Inventories -112 -195 73 133
Change in Payables 74 -18 -45 -0.5
Other Changes -238 -592 39 26.5
Working Capital Change -375 -1031 -45 189
Cash Generated From Operations -802 -2505 -682 -25
Tax -12 -84 -62 -36
Cash Flow From Operations -814 -2589 -744 -61
Purchase of PPE -31 -143 -95 -72
Sale of PPE 1 5 8 10
Cash Flow From Investment 4 -5789 -72 -1261
Borrowing 15 2016 652 -231
Divided 0 0 -23 -29.5
Equity 399.2 6344 548 2000
Others From Financing 605.8 -55 -324 -282.5
Cash Flow from Financing 1020 8305 853 1457
Net Cash Generated 210 -73 37 135
Cash at the Start 20 230 157 192
Cash at the End 230 157 194 327


Shareholding Pattern

  • 2021
  • 2022
  • 2023
  • 2024
Evermed Holdings Pte. Ltd
14.65%
MacRitchie Investments Pte. Ltd
13.74%
Prasid Uno Family Trust Through Its Trustee Surbhi Singh
13.18%
TPG Growth V SF Markets Pte. Ltd
8.73%
Lightrock Growth Fund I SA, SICAV-RAIF, For And On Behalf Of Lightrock Global Fund
6.22%
Others
43.48%
Naspers Ventures B. V
13.24%
Evermed Holdings Pte. Ltd
6.45%
MacRitchie Investments Pte. Ltd.
11.93%
Prasid Uno Family Trust Through Its Trustee Surbhi Singh
6.10%
TPG Growth V SF Markets Pte. Ltd
7.32%
Other
54.96%
Naspers Ventures B. V.
13.24%
Evermed Holdings Pte. Ltd
6.45%
MacRitchie Investments Pte. Ltd
11.93%
Prasid Uno Family Trust Through Its Trustee Surbhi Singh
6.10%
TPG Growth V SF Markets Pte. Ltd
7.32%
Other
54.96%
Naspers Ventures B. V.
13.03%
MacRitchie Investments Pte. Ltd.
11.74%
TPG Growth V SF Markets Pte. Ltd
7.20%
Evermed Holdings Pte. Ltd.
6.35%
Prasid Uno Family Trust Through Its Trustee Surbhi Singh
4.39%
Others
57.29%

Peer Ratio

Particulars (cr) Revenue (Fy24) PAT (Fy24) P/E (17/01/2025) Mcap (17/01/2025)
NCDEX 96 -29 NA 1500 Cr
MCX 684 83 88x 30000 Cr